Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Rekvina Laboratories Ltd (NSE: VINRKLB), ISIN INE092O01028 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
VINRKLB last traded at ₹60.84 (-5.00%), with a 52-week range of ₹6.75 to ₹67.00 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 77.00%, FIIs 0.00%, DIIs 0.00%, mutual funds 0.00%.
Data sourced from NSE and BSE filings. Educational — not investment advice.